Case Reports in Medicine

Case Reports in Medicine / 2013 / Article

Case Report | Open Access

Volume 2013 |Article ID 318358 | 5 pages | https://doi.org/10.1155/2013/318358

Acute Systemic Viral Infection Masquerading as an Infiltrating Lymphoma in an Elderly Patient: A Case Report and Review of the Literature

Academic Editor: Gianfranco D. Alpini
Received12 Nov 2012
Revised13 Jan 2013
Accepted15 Jan 2013
Published12 Feb 2013

Abstract

Primary Epstein-Barr virus (EBV) infection occurs mainly in adolescents and young adults, with more than 90% of adults having serological evidence of past infection. Primary infection in those over the age of 40 is associated with an atypical and often more severe presentation that can lead to more extensive and invasive, and often unnecessary, diagnostic testing. The incidence of severe EBV-related illness in older adults has been observed to be increasing in industrialized nations. The characteristic presentation of infectious mononucleosis (IM) syndrome in elderly patients (age > 65) is not clearly defined in the literature. Here, we describe a case of primary EBV infection in an 80-year-old female and review the literature regarding primary seroconversion in elderly patients.

1. Case Report

An 80-year-old female with a history of idiopathic thrombocytopenic purpura and splenectomy presented to our institution with seven days of fevers at night, chills, night sweats, and weight loss. She lived with her husband and was independent in her activities of daily living. She was asymptomatic one week prior to initial presentation to the emergency room. Upon admission, she appeared fatigued with an exam remarkable for icterus, enlarged right neck and left supraclavicular lymph nodes (LNs), hepatomegaly, and right upper quadrant tenderness. Laboratory tests revealed a WBC of 19.7 × 109/L with a differential of 31% neutrophils, 58% lymphocytes, and 11% monocytes. Liver function tests (LFTs) revealed an alkaline phosphatase of 595 μ/L, aspartate aminotransferase of 281 μ/L, alanine aminotransferase of 200 μ/L, and a total bilirubin of 2 mg/dL. Abdominal ultrasound noted multiple enlarged porta hepatis LNs and findings suggestive of choledocholithiasis. MRCP revealed no choledocholithiasis or ductal dilatation but revealed significant interaortocaval, periportal, and common hepatic enlarged LNs. A CT scan of the chest revealed enlarged bilateral axillary and significant anterior and superior mediastinal LNs suggestive of lymphoma. An infectious disease workup was negative for viral hepatitis, mononucleosis (monospot test), coccidiomycosis, ehrlichiosis, rickettsia, QuantiFERON-TB Gold In-Tube, histoplasmosis, blastomycosis, CMV, and toxoplasmosis, and blood cultures were also negative. An excisional biopsy of a right neck LN revealed an atypical lymphoid proliferation. The surgical team initially recommended a mediastinoscopy with mediastinal LN sampling for a more adequate specimen, but a multidisciplinary group meeting concluded that ultrasound-guided needle percutaneous liver parenchyma and periportal LNs biopsies should be performed due to lower invasiveness and higher diagnostic yield potential. Liver and retroperitoneal LN core biopsies revealed an atypical lymphoid infiltrate (Figures 1(a) and 2(a)). EBV anti-EBNA and anti-VCA IgG/IgM were nonreactive; however, serum EBV DNA by PCR was elevated (146,500 copies/mL), suggesting acute systemic EBV infection. Furthermore, in situ hybridization analysis of the liver and LN tissue specimens was diffusely positive for EBV-encoded RNA (Figures 1(b) and 2(b)), further confirming EBV as the cause of her constellation of symptoms in our seronegative patient. Immunoperoxidase stains of tissue specimen revealed an atypical lymphoid infiltrate composed of a mixed population of both B- and T-cells. A Ki-67 stain indicated that the infiltrate appeared proliferative. Flow cytometric immunophenotyping identified lymphocytes comprising 78% of total cells and consisted of a mixture of phenotypically unremarkable T-cells (66%), polytypic B-cells (32%), and NK cells (2%). There did not appear to be atypical expression of CD4 and CD8 stains. The histologic and flow cytometric immunophenotyping were not diagnostic of a B-cell, T-cell, or Hodgkin’s lymphoma. The patient was started on ganciclovir and subsequently switched to valganciclovir for 3 weeks on discharge. At the time of discharge (after a week of hospitalization) and during followup, the patient was asymptomatic and showed improvement in her liver function test (LFT).

2. Discussion

EBV is the cause of IM and is a virus of the family Herpesviridae, which consists of a linear DNA core surrounded by a nucleocapsid and an envelope that contains glycoprotein. IM occurs most commonly in younger children, with a second peak in adolescence. By adulthood, 90% of individuals have been infected and have antibody to the virus. The incidence of IM in persons over the age of 35 is two to four per 100,000 per year [1]. Young children are asymptomatic or present with mild pharyngitis, fever, fatigue, and myalgia. In contrast, elderly patients present with longer fevers, jaundice, lymphadenopathy, and hepatomegaly [1, 2]. A study of 27 patients with IM aged 40 to 72 years revealed fever during the entire illness occurring in about 93% of elderly patients, with 37% of the patients exhibiting fevers for 14 days [3]. Approximately 52% of the patients in the study also required hospitalization. Posterior cervical, anterior cervical, and absence of lymphadenopathy occurred in 40%, 16%, and 44% of elderly patients, respectively. Elderly patients with IM also have a higher prevalence of hyperbilirubinemia, with levels greater than 2 mg/dL occurring in 30% of patients relative to 3% in patients 35 years of age and younger [1]. The literature review of case reports of elderly patients with IM also revealed significant elevations in bilirubin and LFTs (Table 1). These findings often erroneously mislead clinicians toward a diagnosis of choledocholithiasis [35]. Elderly patients with IM consistently lack lymphocytosis, and the prevalence of heterophile-negative IM increases with age [1, 68]. A study of elderly patients with IM revealed positive titers of anti-EBV-VCA IgM, anti-EBV-VCA IgG, anti-EBV EA-IgG, and anti-EBV-EBNA in 55.6%, 88.9%, 85.2%, and 92.6% of patients, respectively [3]. In contrast to all previously published cases, our patient had negative serologies but showed significant elevation in EBV viral load. Conclusively, in comparison to younger patients with IM elderly patients tend to present with longer duration of illness with prolonged fevers, jaundice, hepatosplenomegaly, generalized lymphadenopathy, and rashes. Laboratory results frequently reveal marked hyperbilirubinemia, significant elevation in LFT, negative heterophile-antibody test, and lack of lymphocytosis (Table 2).


AgeGenderPresenting symptoms and signsAST/ALT
(units/L)
Tbili
(mg/dL)
ALKP/GGT
(units/L)
Atypical lymphocytesSerology/PCRRadiographic studiesLiver biopsy
results
Treatment and outcome

68MMalaise and jaundice.1553/1396Tbili
34
Dbili
25
147/50PresentPos anti-VCA
IgM and negative anti-EBNA.
Normal imaging.No biopsy performed.Supportive management.
Improved during hospitalization [13].

66FMalaise, anorexia, and jaundice.3090/1490Tbili
26.4
Dbili
15.1
318/no GGTPresentPos monospot test, anti-VCA
IgM/IgG, and EBV PCR.
Abd US chronic liver disease changes.Hepatitis and cirrhosis. Prednisolone for AIH.
Asymptomatic at 2-month followup [14].

70FFever, pharyngitis, and back pain.339/390Dbili
0.4
524/no
GGT
PresentPos heterophile antibody and anti-VCA IgM/IgG. No radiographic studies.No Biopsy performed.Supportive treatment [1].

72FSore throat, fever jaundice, splenomegaly, and fever.904/1258Tbili
21.4
DBili
15.9
370/250AbsentPos anti-VCA IgM, EBV PCR, anti-EBEA IgM. Neg anti-VCA IgG.Normal imaging.No Biopsy performed.
Supportive management.
Fatigue at 6-month followup [4].

67FSore throat, fever, jaundice, and RUQ pain.847/499Tbili
11.4
Dbili
8.6
1389/198PresentPos monospot test and anti-VCA IgM/IgG. Normal imaging.Lymphocytic infiltration in
portal tracts.
Supportive management.
Asymptomatic at 3-month followup [4].

83MNight sweat and weight loss.337/407Tbili
10.5
512/no GGTPresentPos heterophile antibody, anti-VCA IgM/IgG, and EBV PCR. CT revealed splenomegaly and lymphadenopathy.No biopsy performed.Supportive management.
Asymptomatic at 1 month [15].

72MLoss of appetite and jaundice.ALT-254Tbili
2.9
677/817PresentPos anti-VCA IgM/IgG and anti-EBNA IgG.CT revealed splenomegaly.No biopsy performed. Supportive management. Asymptomatic at 4 months [16].

76 FFalls and dizziness.Not reportedTbili
5.7
Dbili
1.5
Not reportedAbsentPos anti-VCA IgM/IgG. Neg anti-EBEA and anti-EBNA.CT revealed aortic lymphadenopathy.No biopsy performed.Supportive management. Asymptomatic at 6 months [17].

73FFalls and dizziness.Not reportedTbili
1.2
Dbili
0.3
Not reportedAbsentPos anti-VCA IgM/IgG. Neg anti-EBEA and anti-EBNA.Normal imaging.No biopsy performed.Supportive management. Asymptomatic at 6 months [17].

Abd US: abdominal ultrasound; AIH: autoimmune hepatitis; ALKP: alkaline phosphatase; ALT: alanine aminotransferase; anti-EBEA: anti-EBV early antigen antibody; anti-EBNA: anti-EBV-associated nuclear antigen antibody; anti-VCA: EBV anti-viral caspid antigen antibody; AST: aspartate aminotransferase; Dbili: direct bilirubin; GGT: gamma glutamyl transpeptidase; HIV: human immunodeficiency virus; IgG: immunoglobulin G; IgM: immunoglobulin M; Neg: negative; PCR: polymerase chain reaction; Pos: positive; Tbili: total bilirubin.
References: Dogan et al., 2007 [13], Koay et al., 2008 [14], Axelrod and Finestone, 1990 [1], Tahan et al., 2001 [4], Malfuson et al., 2011 [15], Thoufeeg et al., 2007 [16], and Dourakis et al., 2006 [17].

Symptoms and signs
 Jaundice
 Prolonged fevers
 Hepatosplenomegaly
 Generalized lymphadenopathy
 Rashes
 Rarely neurological symptoms
Laboratory tests
 Lack of lymphocytosis
 Heterophile-negative antibody test (increases with age)
 Significant hyperbilirubinemia
 Elevation in liver function tests
 Positive EBV serology
Outcome
 Protracted duration of illness
 Prolonged hospitalizations
Common workup
 Blood tests including serologies
 Lymph nodes/liver biopsies
 Bone marrow aspiration and biopsies
 Imaging studies including MRI/CT scans
 Bronchoscopies
 ERCP

ERCP: endoscopic retrograde cholangiopancreatography. References: Horwitz et al., 1983 [3], and Axelrod and Finestone, 1990 [1].

EBV infection is associated with the development of B-cell and T-cell non-Hodgkin lymphoma, Hodgkin lymphoma, nasopharyngeal carcinoma, and posttransplant lymphoproliferative disorders [9, 10]. Subsets of patients also develop chronic-active EBV infection that involves progressive and recurrent IM symptoms with organ involvement and high EBV viral load over a longer period [11]. Treatment of EBV IM is usually supportive, and most cases of hepatitis resolve spontaneously. The use of steroids in acute EBV infection is controversial and should be considered only in patients with life-threatening infections. Antiviral medications and steroids reduce oropharyngeal shedding of the virus temporarily but have no clinical benefit compared to placebo [12]. Our patient was successfully treated with antiviral therapy, which resulted in prompt resolution of her presenting complaints. The literature review revealed that supportive care was the mainstay of treatment in elderly patients with EBV IM (Table 1). Presumptive diagnoses such as lymphoma secondary to significant lymphadenopathy, leukemia due to presence of atypical lymphocytosis, choledocholithiasis, or fever of unknown origin (FUO) can lead to delayed diagnosis and unnecessary invasive procedures. These unnecessary procedures in elderly patients with IM are due to both older age at presentation and atypical clinical presentation. Performed procedures include excisional biopsies, bone marrow aspiration and biopsies, bronchoscopies, and endoscopic retrograde cholangiopancreatography [1, 3]. Consideration of this disease entity is essential in elderly patients with presumptive diagnoses of lymphoma, chronic lymphocytic leukemias, cholestatic jaundice, and FUO. Tests for specific EBV antibodies should be obtained, and if negative and clinical suspicion remains high, EBV viral load PCR analysis should be performed. Our case highlights the benefit of antiviral treatment for severe disease in immunocompromised elderly patients, as our patient had a recovery in one week. In addition, our study highlights the importance of a multidisciplinary approach when caring for elderly patients with unusual clinical presentations.

Conflict of Interests

The authors report no conflict of interests.

References

  1. P. Axelrod and A. J. Finestone, “Infectious mononucleosis in older adults,” American Family Physician, vol. 42, no. 6, pp. 1599–1606, 1990. View at: Google Scholar
  2. J. Halevy and S. Ash, “Infectious mononucleosis in hospitalized patients over forty years of age,” American Journal of the Medical Sciences, vol. 295, no. 2, pp. 122–124, 1988. View at: Google Scholar
  3. C. A. Horwitz, W. Henle, and G. Henle, “Infectious mononucleosis in patients aged 40 to 72 years: report of 27 cases, including 3 without heterophil-antibody responses,” Medicine, vol. 62, no. 4, pp. 256–262, 1983. View at: Google Scholar
  4. V. Tahan, R. Ozaras, H. Uzunismail et al., “Infectious mononucleosis presenting with severe cholestatic liver disease in the elderly,” Journal of Clinical Gastroenterology, vol. 33, no. 1, pp. 88–89, 2001. View at: Publisher Site | Google Scholar
  5. Y. Edoute, Y. Baruch, J. Lachter, E. Furman, L. Bassan, and N. Assy, “Case report: severe cholestatic jaundice induced by Epstein-Barr virus infection in the elderly,” Journal of Gastroenterology and Hepatology, vol. 13, no. 8, pp. 821–824, 1998. View at: Google Scholar
  6. K. E. Schmader, C. M. van der Horst, and M. E. Klotman, “Epstein-Barr virus and the elderly host,” Reviews of Infectious Diseases, vol. 11, no. 1, pp. 64–73, 1989. View at: Google Scholar
  7. A. Hornsleth, J. Siggaard-Andersen, and L. Hjort, “Epidemiology of herpesvirus and respiratory virus infections—part 1. Serologic findings,” Geriatrics, vol. 30, no. 8, pp. 61–68, 1975. View at: Google Scholar
  8. C. A. Horwitz, W. Henle, and G. Henle, “Heterophil-negative infectious mononucleosis and mononucleosis-like illnesses. Laboratory confirmation of 43 cases,” American Journal of Medicine, vol. 63, no. 6, pp. 947–957, 1977. View at: Google Scholar
  9. O. A. Odumade, K. A. Hogquist, and H. H. Balfour Jr., “Progress and problems in understanding and managing primary epstein-barr virus infections,” Clinical Microbiology Reviews, vol. 24, no. 1, pp. 193–209, 2011. View at: Publisher Site | Google Scholar
  10. M. J. Goldacre, C. J. Wotton, and D. G. R. Yeates, “Associations between infectious mononucleosis and cancer: record-linkage studies,” Epidemiology and Infection, vol. 137, no. 5, pp. 672–680, 2009. View at: Publisher Site | Google Scholar
  11. M. Okano, K. Kawa, H. Kimura et al., “Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection,” American Journal of Hematology, vol. 80, no. 1, pp. 64–69, 2005. View at: Publisher Site | Google Scholar
  12. D. Torre and R. Tambini, “Acyclovir for treatment of infectious mononucleosis: a meta-analysis,” Scandinavian Journal of Infectious Diseases, vol. 31, no. 6, pp. 543–547, 1999. View at: Google Scholar
  13. I. Dogan, M. Ergun, M. Cindoruk et al., “Acute hepatitis induced by Epstein-Barr virus infection: a case repot,” Turkish Journal of Gastroenterology, vol. 18, no. 2, pp. 119–121, 2007. View at: Google Scholar
  14. L. B. Koay, S. L. Tsai, C. S. Sun et al., “Chronic autoimmune hepatitis with Epstein-Barr virus superinfection: a case report and review of literature,” Hepatogastroentrology, vol. 55, no. 86-87, pp. 1781–1784, 2008. View at: Google Scholar
  15. J. V. Malfuson, F. Dutasta, J. Konopacki et al., “Infectious mononucleosis and monoclonal B lymphocytosis in an elderly man,” Journal of American Geriatric Society, vol. 59, no. 11, pp. 2156–2157, 2011. View at: Google Scholar
  16. M. H. Thoufeeg, S. L. Ali Khan, S. K. Jain et al., “A case of acute infectious mononucleosis presenting with very high ferritin,” World Journal of Gastroenterology, vol. 13, no. 4, pp. 637–638, 2007. View at: Google Scholar
  17. S. P. Dourakis, A. Alexopoulou, N. Stamoulis et al., “Acute Epstein-Barr virus infection in two elderly individuals,” Age Ageing, vol. 35, no. 2, pp. 196–198, 2006. View at: Google Scholar

Copyright © 2013 Hani M. Babiker et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

4716 Views | 646 Downloads | 0 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.